“…Whenever measurement of biologically active ACTH, secretion dynamics or plasma half-life is important, an antiserum should be chosen which shows minimal reaction with non-biologically active fragments. It is also desirable to estimate both C-terminal and N-terminal immunoreactivity when studying the release of ACTH-like peptides from non-endocrine tumours and when monitoring the purity of pituitary extracts (Thomas et al, 1973). The extraction procedure used may also affect specificity, for it is our experience using a silicic acid absorption method that the relative recoveries of ACTH, 8and yLPH are affected by slight changes of methodology.…”